Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wattana Karnpaet PCLBKK:NEW 76 5-Year Yield-on-Cost % is 1.68 as of Jul. 28, 2026, which is 46% above its 10-year median of 1.15. GuruFocus rates BKK:NEW with a GF Score™ of 76/100 and a GF Value™ of ฿96.83 (Fairly Valued). The stock has 1 warning sign investors should review. Among 277 Healthcare Providers & Services companies, Wattana Karnpaet PCL ranks worse than 67.87% on this metric.
Wattana Karnpaet PCL's yield on cost for the quarter that ended in Mar. 2026 was 1.68.
The historical rank and industry rank for Wattana Karnpaet PCL's 5-Year Yield-on-Cost % or its related term are showing as below:
BKK:NEW'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.21 Med: 1.15 Max: 5.26
Current: 1.68
During the past 13 years, Wattana Karnpaet PCL's highest Yield on Cost was 5.26. The lowest was 0.21. And the median was 1.15.
BKK:NEW's 5-Year Yield-on-Cost % is ranked worse than 67.87% of 277
companies
in the Healthcare Providers & Services industry
Industry Median: 2.93
vs BKK:NEW: 1.68
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Wattana Karnpaet PCL 5-Year Yield-on-Cost % Related Terms
BKK:NEW vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Wattana Karnpaet PCL's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wattana Karnpaet PCL 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wattana Karnpaet PCL's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Wattana Karnpaet PCL's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Wattana Karnpaet PCL (BKK:NEW) has a 5-Year Yield-on-Cost % of 1.68 as of Jul. 28, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Wattana Karnpaet PCL and its competitors. This is 46% above median its historical median of 1.15. Over the past decade, Wattana Karnpaet PCL's 5-Year Yield-on-Cost % has ranged from 0.21 to 5.26. According to the industry distribution chart, Wattana Karnpaet PCL ranks #188 out of 277 companies in the Healthcare Providers & Services industry, placing it in the top 67.9%.
Is Wattana Karnpaet PCL's 5-Year Yield-on-Cost % too high?
Wattana Karnpaet PCL's current 5-Year Yield-on-Cost % of 1.68 is 46% above median its 10-year median of 1.15. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 5.26. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.93. Wattana Karnpaet PCL's value of 1.68 is 42.7% below this industry median. Based on the distribution chart, Wattana Karnpaet PCL ranks #188 out of 277 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Wattana Karnpaet PCL has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wattana Karnpaet PCL's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wattana Karnpaet PCL ranks #188 out of 277 companies for 5-Year Yield-on-Cost %. This places Wattana Karnpaet PCL in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. Wattana Karnpaet PCL's value of 1.68 is 42.7% below this benchmark. Historically, Wattana Karnpaet PCL's own 5-Year Yield-on-Cost % has ranged from 0.21 to 5.26 over the past decade. While the company's 10-year median is 1.15 vs. the industry median of 2.93, Wattana Karnpaet PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wattana Karnpaet PCL's current 5-Year Yield-on-Cost % of 1.68 is 42.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Wattana Karnpaet PCL and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wattana Karnpaet PCL's current 5-Year Yield-on-Cost % is 1.68, which is 46% above median its own 10-year median of 1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattana Karnpaet PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattana Karnpaet PCL (BKK:NEW) is currently considered Fairly Valued. The stock's GF Value™ is ฿96.83, compared to a current price of ฿95.00 — trading 1.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.68, which is 46% above median its 10-year median of 1.15 and 42.7% below the Healthcare Providers & Services industry median of 2.93. Wattana Karnpaet PCL's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Wattana Karnpaet PCL (BKK:NEW), the current 5-Year Yield-on-Cost % is 1.68 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wattana Karnpaet PCL (BKK:NEW) Overvalued in 2026?
Based on GuruFocus' analysis, Wattana Karnpaet PCL stock appears to be undervalued.
The current stock price of ฿95.00 is trading 1.9% below its estimated GF Value™ of ฿96.83.
GuruFocus considers Wattana Karnpaet PCL to be Fairly Valued.
Key valuation signals for BKK:NEW:
5-Year Yield-on-Cost %: 1.68 (46% above median its 10-year median of 1.15)
GF Value™: ฿96.83 vs. price of ฿95.00 (1.9% below fair value)
Industry Position: 42.7% below the Healthcare Providers & Services median (#188 of 277)
No single metric tells the full story. See the BKK:NEW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wattana Karnpaet PCL is engaged in the operation of a hospital under the name North Eastern Wattana Hospital. It has a single segment of operation, namely the hospital and medical trading business. The company earns revenue from hospital, revenue from sales of medicines, and revenue from hospital rooms, which are derived from the provision of services to various types and a large number of customers. Geographically, the company's operations are carried out in Thailand.
76GF Score
Get the complete analysis for BKK:NEW
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NEW has been successfully added to your 
